Ibex Unveils Advancements in AI Breast Cancer Diagnostics Platform
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Read MorePosted by Andy Lundin | Sep 5, 2024 | Breast, Digital Pathology |
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Prostate |
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Unknown Origin & Other Cancer Types |
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MorePosted by Andy Lundin | Jul 26, 2024 | Prostate |
Studies indicate men with BRCA1 and BRCA2 mutations face significant cancer risks, prompting new national screening guidelines.
Read More